A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris
Phase of Trial: Phase II
Latest Information Update: 16 Dec 2017
At a glance
- Drugs IDP 126 (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Ortho Dermatologics; Valeant Pharmaceuticals International
- 11 Dec 2017 Status changed from not yet recruiting to recruiting.
- 27 Jul 2017 According to Valeant Pharmaceuticals International media release, Valeant Pharmaceuticals International renamed its dermatolgy unit as Ortho Dermatologics.
- 05 Jun 2017 New trial record